Wyeth sues J&J over stent drug
Executive Summary
Wyeth sues Johnson & Johnson in Delaware federal court Oct. 26, seeking to break agreement to supply J&J's Cordis unit with Rapamune (sirolimus), the immunosuppressant used on the Cypher drug-eluting stent. Suit alleges material breach of contract and seeks damages, charging Cordis with failing to make "commercially reasonable" efforts to develop CCI 779, a sirolimus analog, as required under their agreement...
You may also be interested in...
US FDA Needs Plan For Addressing Inspection Backlog Post-COVID, GAO Says
Agency must plan to ensure that a growing backlog of surveillance inspections does not impede its ability to conduct inspections at high-risk sites, GAO official says.
Health And Wellness Trademark Review 2 March, 2021
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
In Order Shutting Down New York Supplement Firm, Federal Judge Also Criticizes FDA’s Calculations
Judge ordering permanent injunction against Confidence USA on a complaint filed in 2019 questioned FDA's calculations for requiring the firm to recall and destroy all products it had distributed since February 2018.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: